共 3 条
[2]
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2006, 295 (07)
:761-775